These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9728551)
21. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. King AE; Critchley HO; Kelly RW Mol Hum Reprod; 2000 Feb; 6(2):191-6. PubMed ID: 10655462 [TBL] [Abstract][Full Text] [Related]
22. Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. Taggart CC; Lowe GJ; Greene CM; Mulgrew AT; O'Neill SJ; Levine RL; McElvaney NG J Biol Chem; 2001 Sep; 276(36):33345-52. PubMed ID: 11435427 [TBL] [Abstract][Full Text] [Related]
24. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Moriyama A; Shimoya K; Ogata I; Kimura T; Nakamura T; Wada H; Ohashi K; Azuma C; Saji F; Murata Y Mol Hum Reprod; 1999 Jul; 5(7):656-61. PubMed ID: 10381821 [TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity. Jana NK; Gray LR; Shugars DC J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026 [TBL] [Abstract][Full Text] [Related]
26. Analysis of the extracellular proteases of Trichomonas vaginalis. Garber GE; Lemchuk-Favel LT Parasitol Res; 1994; 80(5):361-5. PubMed ID: 7971921 [TBL] [Abstract][Full Text] [Related]
27. Distribution of the secretory leucocyte proteinase inhibitor in human articular cartilage. Ohlsson S; Tufvesson B; Polling A; Ohlsson K Biol Chem; 1997 Sep; 378(9):1055-8. PubMed ID: 9348116 [TBL] [Abstract][Full Text] [Related]
28. Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Provenzano D; Alderete JF Infect Immun; 1995 Sep; 63(9):3388-95. PubMed ID: 7642267 [TBL] [Abstract][Full Text] [Related]
29. Comparison between secretory leukocytic protease inhibitor and reactive nitrogen intermediates levels in cervicovaginal secretions from symptomatic and asymptomatic trichomoniasis Egyptians patients. Al-Mohammed HI; Hussein EM J Egypt Soc Parasitol; 2006 Dec; 36(3):763-77. PubMed ID: 17153694 [TBL] [Abstract][Full Text] [Related]
30. Endogenous salivary inhibitors of human immunodeficiency virus. Shugars DC; Alexander AL; Fu K; Freel SA Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522 [TBL] [Abstract][Full Text] [Related]
31. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein. Shine NR; Wang SC; Konopka K; Burks EA; Düzgüneş N; Whitman CP Bioorg Chem; 2002 Aug; 30(4):249-63. PubMed ID: 12392704 [TBL] [Abstract][Full Text] [Related]
32. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. Ohlsson K; Bjartell A; Lilja H J Androl; 1995; 16(1):64-74. PubMed ID: 7539415 [TBL] [Abstract][Full Text] [Related]
33. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy. Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266 [TBL] [Abstract][Full Text] [Related]
34. Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue. Into T; Inomata M; Kanno Y; Matsuyama T; Machigashira M; Izumi Y; Imamura T; Nakashima M; Noguchi T; Matsushita K Clin Exp Immunol; 2006 Sep; 145(3):545-54. PubMed ID: 16907925 [TBL] [Abstract][Full Text] [Related]
35. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis. Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825 [TBL] [Abstract][Full Text] [Related]
36. Salivary secretory leukocyte protease inhibitor increases in HIV infection. Lin AL; Johnson DA; Stephan KT; Yeh CK J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833 [TBL] [Abstract][Full Text] [Related]
37. Trichomonas vaginalis: characterization of a 39-kDa cysteine proteinase found in patient vaginal secretions. Hernández-Gutiérrez R; Avila-González L; Ortega-López J; Cruz-Talonia F; Gómez-Gutierrez G; Arroyo R Exp Parasitol; 2004; 107(3-4):125-35. PubMed ID: 15363938 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor. Mulligan MS; Lentsch AB; Huber-Lang M; Guo RF; Sarma V; Wright CD; Ulich TR; Ward PA Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546 [TBL] [Abstract][Full Text] [Related]
40. Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity. Konopka K; Shine N; Pretzer E; Düzgüneş N J Dent Res; 1999 Dec; 78(12):1773-6. PubMed ID: 10598905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]